Arizona Health Sciences

Medicine & Life Sciences

1. Depression 100%
2. Tryptophan 95%
3. Serotonin 77%
4. Vagus Nerve Stimulation 68%
5. Antidepressive Agents 63%
6. Treatment-Resistant Depressive Disorder 60%
7. Serotonin Plasma Membrane Transport Proteins 43%
8. Obsessive-Compulsive Disorder 41%
9. Major Depressive Disorder 32%
10. Cerebrospinal Fluid 30%
11. Psilocybin 29%
12. Mirtazapine 27%
13. Hispanic Americans 25%
14. Serotonin Uptake Inhibitors 22%
15. Hallucinogens 20%
16. Genetic Promoter Regions 19%
17. Genes 18%
18. Psychiatry 18%
19. Therapeutics 18%
20. Catecholamines 17%
21. Norepinephrine 17%
22. Genotype 16%
23. Primary Health Care 16%
24. Anxiety 16%
25. Alleles 15%
26. Brain 13%
27. Spinal Puncture 13%
28. Cognitive Remediation 13%
29. Respiratory Sinus Arrhythmia 12%
30. Pindolol 12%
31. Randomized Controlled Trials 11%
32. Sertraline 11%
33. Anxiety Disorders 11%
34. Desipramine 11%
35. Orgasm 11%
36. Multifactorial Inheritance 10%
37. Unemployment 10%
38. Carnitine 10%
39. Neuroticism 10%
40. Mentally Ill Persons 10%
41. Fluoxetine 10%
42. Valproic Acid 9%
43. Recurrence 9%
44. Acupuncture 9%
45. Substance P 9%
46. IDS 30 9%
47. Hydroxyindoleacetic Acid 9%
48. Genetic Polymorphisms 9%
49. Equipment and Supplies 8%
50. Psychological Distress 8%
51. Corpus Striatum 8%
52. Neurotransmitter Agents 8%
53. Internet 8%
54. Individuality 8%
55. Population 8%
56. gamma-Aminobutyric Acid 8%
57. Postpartum Period 8%
58. Sex Characteristics 8%
59. Psychotic Disorders 8%
60. Healthy Volunteers 8%
61. Suicide 8%
62. Synaptic Transmission 8%
63. Pharmaceutical Preparations 7%
64. Reproducibility of Results 7%
65. Mood Disorders 7%
66. Mental Health 7%
67. Pharmacokinetics 7%
68. Aptitude 7%
69. Learning 7%
70. acylcarnitine 7%
71. Income 7%
72. Case-Control Studies 7%
73. Electroconvulsive Therapy 7%
74. Emotions 6%
75. Observational Studies 6%
76. Homovanillic Acid 6%
77. Biomedical Research 6%
78. Safety 6%
79. Psychopathology 6%
80. Chronic Disease 6%
81. Placebos 6%
82. Penile Erection 6%
83. Lubrication 5%
84. Serotonin 5-HT2 Receptor Agonists 5%
85. Diagnostic and Statistical Manual of Mental Disorders 5%
86. Medically Unexplained Symptoms 5%
87. Cross-Sectional Studies 5%
88. Health 5%
89. Prospective Studies 5%
90. Receptor, Serotonin, 5-HT2C 5%
91. Pregnancy 5%
92. Psychological Stress 5%